Pharmaceutical Business review

Meridian wins FDA clearance for new campylobacter test

According to the company, there is a significant need for the Premier Campy test because it provides a solution to several concerns associated with culture testing, currently the most commonly practiced lab technique for detecting the campylobacter bacteria.

Premier Campy dramatically reduces these concerns with a consistent enzyme immunoassay method that measures the antigen instead of the fragile bacteria in an environment that is less inhibitory than current culturing procedures, the company claimed.

John Kraeutler, CEO of Meridian, said: “This new assay solidifies our position as a leader in rapid, accurate testing methods in food borne testing. Premier Campy is already in distribution via Meridian Bioscience Europe for the company’s European markets and was also recently approved for sale in Canada.”